Drugs Made In America Acquisition Corp.

CIK: 2028614Ticker: DMAA

SPAC Overview

$500M
IPO Size
Unit Split
Current Status
2025
IPO Year

Timeline Progress

About

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region although we intend to focus our search for business combination targets in the pharmaceutical industry.

Stock Performance

DMAA
Trading Symbol
First Trade
February 25, 2025
$9.98
Current Price
May 30, 2025
$10.13
+2%

Key Information

January 9, 2025
DMAA